2023-01-25 16:36:00

Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer

Logo GlobeNewswire

SAN LEANDRO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (Nanomix or the Company), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced the appointment of Christopher R. Hetterly as Chief Financial Officer (CFO).

Mr. Hetterly is a financial executive and entrepreneur, with over 25 years of financial leadership and banking experience. Previously, Mr. Hetterly was the CFO of Octagos Health, a healthcare Software-as-a-Service (SaaS) company. Prior to that, he was a CFO at Madrona Ventures portfolio companies. Mr. Hetterly was the Head of Technology Finance at GE Capital, Wells Fargo, and East West Bank, in addition to being CFO/CIO at Palo Alto Capital. He has raised capital from seed stage to IPO and beyond, and has experience in debt and equity financing, corporate development, business development, with particular expertise in building finance teams and leading in high growth environments. Mr. Hetterly has raised over $10 billion in capital in his career for well-known names such as eBay, Netflix and Symantec amongst others, and his financing experience includes venture capital, corporate, mezzanine, lease, bank credit line, LBO, IPO and secondary public sources. He graduated from Brown University with a BA from the Honors Program.

Thomas Schlumpberger, Nanomix CEO, stated, We are excited to welcome Chris to the Nanomix management team as our CFO. Chris has more than 25 years in senior financial roles encompassing debt and equity financing, corporate development, and business development. His experience and leadership will be invaluable as we work to establish our technology as a standard of care in POC diagnostics.

About Nanomix Corporation

Nanomix (OTCQB: NNMX) is developing mobile point-of-care diagnostics with its Nanmix eLabSystem platform and assays that provide rapid, accurate, quantitative information for use in settings where time is critical to clinical decision-making and improved patient care. The companys products are designed to broadly impact healthcare delivery by bringing diagnostics to the point of initial patient interaction, whether in the hospital or in pre-hospital, remote or alternate-care settings, thereby enabling faster clinical decision-making and potentially treatment-in-place. Nanomixs first assays address the need for faster diagnosis of critical infections including sepsis. The company is developing a pipeline of other tests designed to improve patient outcomes by making high-quality diagnostic information available within minutes. For more information, visit www.nanomixdx.com.

Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements within the meaning of the federal securities laws. Forward looking statements include statements regarding the Companys intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Companys ongoing and planned product development; the Companys intellectual property position; the Companys ability to develop commercial functions; expectations regarding product launch and revenue; the Companys results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section entitled Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as well as discussions of potential risks, uncertainties, and other important factors in the Companys subsequent filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:
Natalya Rudman
Crescendo Communications, LLC
Email: NNMX@crescendo-ir.com
Tel: (212) 671-1020 Ext.304

Continue read on globenewswire.com

Logo GlobeNewswire
TechnologyPress Release2023-01-25 12:00:00
LeRoy is a top industry veteran who was pivotal in SailPoints 5x value increase, culminating in acquisition NASHVILLE, Tenn., Jan. 25, 2023 (GLOBE NEWSWIRE)...

Logo PR Newswire
TechnologyPress Release2023-01-24 18:00:00
CEO Shawn Boom Promoted to Executive Chairman BLOOMINGTON, Minn., Jan. 24, 2023 /PRNewswire/ -- Vanco, the market's leading provider of payment solutions to...

Logo GlobeNewswire
TechnologyPress Release2023-01-25 16:15:00
Sharpens EFIs focus as a leading industrial inkjet pure-play and Fierys position as the leading DFE provider LONDONDERRY, N.H. and FREMONT, Calif., Jan. 25,...

Logo PR Newswire
HealthPress Release2023-01-24 18:30:00
Founder, previous CEO and chairman tapped to lead pharmaceutical services company in next stage of accelerated growth WHIPPANY, N.J., Jan. 24, 2023...

Logo PR Newswire
MONTREAL, Jan. 24, 2023 /CNW/ - Mobi724 Global Solutions Inc. ("Mobi724" or the "Company") (TSXV: MOS), a fintech enabler of AI-powered payment card-linked...

Logo PR Newswire
TechnologyPress Release2023-01-25 14:00:00
ATLANTA, Jan. 25, 2023 /PRNewswire/ -- Coginiti Corp, the market leader in collaborative intelligence, today announced that J. Dale Belt joined its...

Logo Channel NewsAsia
Business / FinanceBy Cna2023-01-24 07:25:28
Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide Best News Website or Mobile Service Digital Media Awards Worldwide LONDON :...

Logo GlobeNewswire
SciencePress Release2023-01-25 13:01:00
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on...

Logo Daily Mail
Business / FinanceBy Daily2023-01-24 22:42:18
THG has reshuffled its top team in a bid to revive its fortunes. The troubled ecommerce business formerly The Hut Group said board member Damian Sanders, a...

Logo GlobeNewswire
SciencePress Release2023-01-23 21:05:00
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment...

Logo PR Newswire
TULSA, Okla., Jan. 25, 2023 /PRNewswire/ -- Sage Natural Resources, LLC ("Sage" or the "Company") announced today that Josh C. Anders has joined the Company...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-25 12:06:00
Extreme Networks, Inc. EXTR, a leader in cloud networking, today announced that its CFO, Rmi Thomas, has accepted a position at a privately held software...

Logo PR Newswire
Health Care Firm Expands Resources to Support Companies' Goals for Accelerating Growth and Creating Value CHICAGO, Jan. 25, 2023 /PRNewswire/ -- Water Street...

Logo American Banker
Business / FinanceBy Miriam Cross2023-01-24 18:35:42
Over the past year, Provident Bank has been rethinking how it defines top tech leadership roles as it prepares to double in size in a pending merger. The...

Logo PR Newswire
Former Senior Vice President of STS Capital Partners Sean Friday is appointed new CEO while Founder and former CEO, Rob Follows, scales to Chairman...

Logo The Business Journals
Technology2023-01-24 23:25:01
Peluffo will replace Mark Wise who recently announced his retirement after serving the company for 11 years.

Logo PR Newswire
HealthPress Release2023-01-25 14:30:00
CMO hire completes CEO Dr. Jessica Henderson Boyd's senior leadership team as organization launches bold three-year strategic plan WASHINGTON, Jan. 25, 2023...

Logo PR Newswire
HealthPress Release2023-01-25 12:00:00
Kelly Henderson named chief operating officer and Kevin Bretcher named chief revenue officer INDIANAPOLIS, Jan. 25, 2023 /PRNewswire/ -- CertaSite, a...

Logo PR Newswire
HealthPress Release2023-01-25 13:00:00
- Dr. Kent brings greater than two decades of global industry experience to leadership team – - Appointment supports the global Phase 2b LIDS clinical trial...

Logo Benzinga
Business / FinanceBy Pr Newswire2023-01-24 20:15:00
Appointment of growth-minded, channel-friendly IT and cybersecurity marketing veteran signals company's bold plans for 2023 MINNEAPOLIS, Jan. 24, 2023...